Mechanism and therapeutic implications of pomalidomide-induced immune surface marker upregulation in EBV-positive lymphomas
Hannah K. Jaeger(National Cancer Institute), Robert Yarchoan(National Cancer Institute)
Cited by 4
Related Papers
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy
|Science Translational Medicine|2022|101